0 avis
Utilization and quality of palliative care in patients with hematological and solid cancers : a population-based study
Article indépendant
BACKGROUND: Palliative care (PC) contributes to improved end-of-life care for patients with hematologic malignancies (HM) and solid tumors (ST) by addressing physical and psychological symptoms and spiritual needs. Research on PC in HM vs. ST patients is fragmented and suggests less use.
METHODS: We analyzed claims data of all deceased members of a large German health insurance provider for the year before death. First, we analyzed the frequency and the beginning of different types of PC and compared patients with HM vs. ST. Second, we analyzed the adjusted impact of PC use on several end-of-life quality outcomes in patients with HM vs. ST. We performed simple and multiple (logistic) regression analysis, adjusted for relevant covariates, and standardized for age and sex.
RESULTS: Of the 222,493 deceased cancer patients from 2016 to 2020, we included 209,321 in the first analysis and 165,020 in the second analysis. Patients with HM vs. ST received PC less often (40.4 vs. 55.6%) and later (34 vs. 50 days before death). PC use significantly improved all six quality indicators for good end-of-life care. HM patients had worse rates in five of the six indicators compared with ST patients. Interaction terms revealed that patients with ST derived greater benefit from PC in five of six quality indicators than those with HM.
CONCLUSION: The data highlight the need to integrate PC more often, earlier, and more effectively into the care of patients with HM.
http://dx.doi.org/10.1007/s00432-024-05721-6
Voir la revue «Journal of cancer research and clinical oncology, 150»
Autres numéros de la revue «Journal of cancer research and clinical oncology»
Consulter en ligne
Suggestions
Du même auteur
De la même série